Finance
Markets

EW

stock
Edwards Lifesciences
$85.78 +2.58 (+3.10%) Last close · May 22

Key statsas of May 22

The day open and close within the day's range
Low $83.12 High $86.03
Open
$83.45
+0.30%
Close
$85.78
+3.10%
52-week range where the price sits across its year
52w low $72.30 52w high $87.89
Current
$85.78
Prev close
$83.20
Volume 1.0× the 3-month average
0 avg 2× avg
Today
4.94M
3-mo avg
4.92M

Stock health

A read across the data this app already carries: fundamentals, recent price and growth trajectory, and leadership stability. Industry context is not yet folded in.

For fun and reading at a glance. Not investment advice and not a buy or sell signal.

Healthy

Overall, EW reads as healthy.

  • Fundamentals Strong across the nine graded ratios
  • Trajectory Climbing trailing-year price trend + revenue / earnings growth
  • Leadership — leadership sync has not reached this stock yet

Fundamentalssynced from SEC 1h ago

Strong

Across the nine graded ratios (FY2025 figures against the latest price), EW’s fundamentals read as strong overall.

P/E ratio Weak
46.9x

At 47x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
17.7%

A 17.7% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
10.4%

A 10.4% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
7.8%

A 7.8% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.32

At 0.32, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
3.72

At 3.72, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Strong
+11.5%

Revenue grew 11.5% from the prior year: strong top-line expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-74.3%

Net income fell 74.3% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 1h ago

FY2021FY2022FY2023FY2024FY2025
Revenue $5.2B$4.5B$5.0B$5.4B$6.1B
Net income $1.5B$1.5B$1.4B$4.2B$1.1B
Diluted EPS $2.38$2.44$2.30$6.97$1.83
Dividend / share —————
Total assets $8.5B$8.3B$9.4B$13.1B$13.7B
Total liabilities $2.7B$2.5B$2.6B$3.0B$3.4B
Shareholder equity $5.8B$5.8B$6.7B$10.0B$10.3B

Leadership

Leadership data for EW has not synced yet. It lands on the next SEC data refresh; see data health.

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Recent SEC filingssynced from SEC 1h ago